<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03709524</url>
  </required_header>
  <id_info>
    <org_study_id>KIA 2018/446</org_study_id>
    <nct_id>NCT03709524</nct_id>
  </id_info>
  <brief_title>Orotracheal Intubation in Adult Patients: A Comparison of Standard Airtraq , Nasotracheal Airtraq Combined With a Stylet Inserted Endotracheal Tube and Standard Airtraq Combined Fiberoptic Intubation</brief_title>
  <official_title>A Comparison of Airtraq and Nasotracheal Airtraq for Orotracheal Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult patients requiring endotracheal intubation divided into three groups; standard Airtraq,
      Nasotracheal Airtraq + styletted endotracheal tube and Airtraq + fiberoptic combination
      groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We enroll lean adult patients requiring endotracheal intubation. Using a sealed envelope
      technique they divided into three groups; Standard Airtraq and Nasotracheal Airtraq +
      styletted endotracheal tube and Standard Airtraq + fiberoptic combination. Demographic
      characteristics and airway management variables such; age, gender, height, weight, ASA
      status, tooth morphology, tiro mental and sternomental distance were recorded. Insertion
      times, intubation times and total intubation times with these devices will be recorded.
      Hemodynamic parameters recorded such as; heart rate will be recorded baseline , after
      anesthesia, after insertion, just after and then every 2 minutes intervals after intubation.
      sore throat, hoarseness, dysphasia, bronchospasm were also recorded postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Actual">February 20, 2019</completion_date>
  <primary_completion_date type="Actual">February 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intubation time</measure>
    <time_frame>6 months</time_frame>
    <description>entering the oral cavity till intubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>insertion time</measure>
    <time_frame>6 months</time_frame>
    <description>entering the oral cavity till the optimal visualization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">119</enrollment>
  <condition>Difficult Intubation</condition>
  <arm_group>
    <arm_group_label>insertion time</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 minute Airtraq, nasotracheal Airtraq + styletted tube and airtraq + fiberoptic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intubation time</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 minutesAirtraq, nasotracheal Airtraq + styletted tube and airtraq + fiberoptic</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Airtraq + fiberoptic</intervention_name>
    <description>video laryngoscope with a monitor</description>
    <arm_group_label>insertion time</arm_group_label>
    <arm_group_label>intubation time</arm_group_label>
    <other_name>videolaryngoscope</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Airtraq</intervention_name>
    <description>video laryngoscope with a monitor</description>
    <arm_group_label>insertion time</arm_group_label>
    <arm_group_label>intubation time</arm_group_label>
    <other_name>videolaryngoscope</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasotracheal Airtraq + styletted tube</intervention_name>
    <description>video laryngoscope with a monitor</description>
    <arm_group_label>insertion time</arm_group_label>
    <arm_group_label>intubation time</arm_group_label>
    <other_name>videolaryngoscope</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI&lt;30

          -  &gt; 18 AGE

          -  requiring endotracheal intubation

          -  ASA 1-2

        Exclusion Criteria:

          -  BMI&gt; 30

          -  &lt; 18 AGE

          -  ASA III-IV

          -  upper respiratory infection past ten days

          -  pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kocaeli University Medical Faculty</name>
      <address>
        <city>Kocaeli</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>October 12, 2018</study_first_submitted>
  <study_first_submitted_qc>October 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2018</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli University</investigator_affiliation>
    <investigator_full_name>Zehra Ipek ARSLAN</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

